Phase-III demarcates deterioration of RA due to the induction of cell death, primarily by synovial apoptosis mediated by activated T cells and NK cells through the interaction of cell surface molecules of the TNF family, namely, the Fas antigen (CD95) and the Fas ligand (Fas-L). The gene discussed is FAS; the disease is rheumatoid arthritis.